Page last updated: 2024-08-23

torsemide and Endomyocardial Fibrosis

torsemide has been researched along with Endomyocardial Fibrosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afanas'ev, SA; Nevdakh, AE; Repin, AN; Rogovskaia, IuB	1
Klues, HG; Martin, N; Ott, R	1
Díez, J; González, A; Larman, M; López, B; Querejeta, R; Sánchez, E	1

Trials

1 trial(s) available for torsemide and Endomyocardial Fibrosis

Article	Year
Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. Journal of the American College of Cardiology, 2004, Jun-02, Volume: 43, Issue:11 Topics: Collagen Type I; Diuretics; Echocardiography; Endomyocardial Fibrosis; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pilot Projects; Sulfonamides; Torsemide; Treatment Outcome	2004

Other Studies

2 other study(ies) available for torsemide and Endomyocardial Fibrosis

Article	Year
[Influence of the long-term administration of torasemide on morphometric characteristics of cardiac muscle under conditions of developed experimental postinfarction cardiosclerosis]. Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:9 Topics: Animals; Antihypertensive Agents; Chronic Disease; Disease Models, Animal; Drug Administration Schedule; Endocardium; Endomyocardial Fibrosis; Heart Failure; Histocytochemistry; Myocardium; Rats; Rats, Wistar; Sulfonamides; Torsemide; Treatment Failure	2013
[Idiopathic hypereosinophilia with cardiac involvement]. Deutsche medizinische Wochenschrift (1946), 2004, Mar-12, Volume: 129, Issue:11 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiomyopathy, Restrictive; Cardiotonic Agents; Diagnosis, Differential; Digoxin; Diuretics; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Endomyocardial Fibrosis; Female; Humans; Hypereosinophilic Syndrome; Magnetic Resonance Imaging; Mineralocorticoid Receptor Antagonists; Mitral Valve Insufficiency; Patient Compliance; Prognosis; Spironolactone; Sulfonamides; Torsemide	2004

Article

Year

[Influence of the long-term administration of torasemide on morphometric characteristics of cardiac muscle under conditions of developed experimental postinfarction cardiosclerosis].

Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:9

Topics: Animals; Antihypertensive Agents; Chronic Disease; Disease Models, Animal; Drug Administration Schedule; Endocardium; Endomyocardial Fibrosis; Heart Failure; Histocytochemistry; Myocardium; Rats; Rats, Wistar; Sulfonamides; Torsemide; Treatment Failure

2013

[Idiopathic hypereosinophilia with cardiac involvement].

Deutsche medizinische Wochenschrift (1946), 2004, Mar-12, Volume: 129, Issue:11

Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiomyopathy, Restrictive; Cardiotonic Agents; Diagnosis, Differential; Digoxin; Diuretics; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Endomyocardial Fibrosis; Female; Humans; Hypereosinophilic Syndrome; Magnetic Resonance Imaging; Mineralocorticoid Receptor Antagonists; Mitral Valve Insufficiency; Patient Compliance; Prognosis; Spironolactone; Sulfonamides; Torsemide

2004